NO975862L - P-selektinligander og relaterte molekyler og fremgangsmåter - Google Patents
P-selektinligander og relaterte molekyler og fremgangsmåterInfo
- Publication number
- NO975862L NO975862L NO975862A NO975862A NO975862L NO 975862 L NO975862 L NO 975862L NO 975862 A NO975862 A NO 975862A NO 975862 A NO975862 A NO 975862A NO 975862 L NO975862 L NO 975862L
- Authority
- NO
- Norway
- Prior art keywords
- methods
- ligands
- determinant
- selectin ligands
- related molecules
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4727—Mucins, e.g. human intestinal mucin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/473—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used alpha-Glycoproteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Abstract
Her er beskrevet organiske molekyler som har bundet via en kovalent binding en sialyl-Le" determinant og en sulfatert determinant, der minst en av disse determinanter er plassert på et ikke-naturlig område på molekylet. Det beskrives også spesielle P-selektinligander og P-selektinligand antistoff fusjoner. Disse molekyler, ligander og fusjonsproteiner er til bruk i fremgangsmåter for å redusere eller beskytte mot betennelse og uønskede reaksjoner avhengig av blodårelekkasje, slik som organskade og blodlevring (for eksempel assosiert med voksent respiratorisk lidelsessyndrom eller ischemisk hjerteskade).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21395P | 1995-06-14 | 1995-06-14 | |
PCT/US1996/010043 WO1997000079A1 (en) | 1995-06-14 | 1996-06-11 | P-selectin ligands and related molecules and methods |
Publications (2)
Publication Number | Publication Date |
---|---|
NO975862D0 NO975862D0 (no) | 1997-12-12 |
NO975862L true NO975862L (no) | 1998-02-12 |
Family
ID=21690430
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO975862A NO975862L (no) | 1995-06-14 | 1997-12-12 | P-selektinligander og relaterte molekyler og fremgangsmåter |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0833650A4 (no) |
JP (1) | JPH11508131A (no) |
KR (1) | KR19990022954A (no) |
AR (1) | AR003436A1 (no) |
AU (1) | AU6272996A (no) |
BR (1) | BR9608918A (no) |
CA (1) | CA2224625A1 (no) |
CZ (1) | CZ401497A3 (no) |
HU (1) | HUP9901131A2 (no) |
IL (1) | IL122590A0 (no) |
NO (1) | NO975862L (no) |
TR (1) | TR199701620T1 (no) |
WO (1) | WO1997000079A1 (no) |
ZA (1) | ZA965032B (no) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999043834A2 (en) * | 1998-02-27 | 1999-09-02 | Genetics Institute, Inc. | P-selectin ligand protein, including tetrameric fusion proteins |
MXPA03005945A (es) * | 2000-12-29 | 2004-10-15 | Savient Pharmaceuticals Inc | Moleculas aisladas que comprenden epitopes que contienen grupos sulfato, anticuerpos para tales epitopes y usos de ellos. |
JP4599027B2 (ja) * | 2002-10-30 | 2010-12-15 | 東洋水産株式会社 | L−セレクチン結合阻害剤 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0544815A1 (en) * | 1990-07-17 | 1993-06-09 | The Board Of Regents Of The University Of Oklahoma | Peptides from the GMP-140 lectinbindingdomain and selectin binding ligands on carbonhydrates |
US5318890A (en) * | 1991-05-06 | 1994-06-07 | The Regents Of The University Of California | Assays for inhibitors of leukocyte adhesion |
AU681369B2 (en) * | 1992-11-16 | 1997-08-28 | Board Of Regents Of The University Of Oklahoma, The | Glycoprotein ligand for P-selectin and methods of use thereof |
WO1995030001A2 (en) * | 1994-04-28 | 1995-11-09 | Genetics Institute, Inc. | Novel p-selectin ligand protein |
-
1996
- 1996-06-11 WO PCT/US1996/010043 patent/WO1997000079A1/en not_active Application Discontinuation
- 1996-06-11 TR TR97/01620T patent/TR199701620T1/xx unknown
- 1996-06-11 KR KR1019970709424A patent/KR19990022954A/ko not_active Application Discontinuation
- 1996-06-11 JP JP9503258A patent/JPH11508131A/ja active Pending
- 1996-06-11 IL IL12259096A patent/IL122590A0/xx unknown
- 1996-06-11 CZ CZ974014A patent/CZ401497A3/cs unknown
- 1996-06-11 BR BR9608918A patent/BR9608918A/pt not_active Application Discontinuation
- 1996-06-11 HU HU9901131A patent/HUP9901131A2/hu unknown
- 1996-06-11 EP EP96921519A patent/EP0833650A4/en not_active Withdrawn
- 1996-06-11 AU AU62729/96A patent/AU6272996A/en not_active Abandoned
- 1996-06-11 CA CA002224625A patent/CA2224625A1/en not_active Abandoned
- 1996-06-13 AR ARP960103147A patent/AR003436A1/es unknown
- 1996-06-13 ZA ZA965032A patent/ZA965032B/xx unknown
-
1997
- 1997-12-12 NO NO975862A patent/NO975862L/no unknown
Also Published As
Publication number | Publication date |
---|---|
AR003436A1 (es) | 1998-08-05 |
CZ401497A3 (cs) | 1998-07-15 |
IL122590A0 (en) | 1998-06-15 |
ZA965032B (en) | 1997-03-14 |
CA2224625A1 (en) | 1997-01-03 |
AU6272996A (en) | 1997-01-15 |
KR19990022954A (ko) | 1999-03-25 |
TR199701620T1 (xx) | 1998-05-21 |
EP0833650A1 (en) | 1998-04-08 |
JPH11508131A (ja) | 1999-07-21 |
NO975862D0 (no) | 1997-12-12 |
BR9608918A (pt) | 1999-06-15 |
EP0833650A4 (en) | 2005-01-19 |
WO1997000079A1 (en) | 1997-01-03 |
HUP9901131A2 (hu) | 1999-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Parham et al. | Carbohydrate moeity of HLA antigens. Antigenic properties and amino acid sequences around the site of glycosylation | |
Feinstein et al. | Conformation of the free and antigen-bound IgM antibody molecules | |
Berndt et al. | Purification and preliminary physicochemical characterization of human platelet membrane glycoprotein V. | |
Perutz | Nature of haem–haem interaction | |
Benesch et al. | The interaction of hemoglobin and its subunits with 2, 3-diphosphoglycerate. | |
Marder et al. | High Molecular Weight Derivatives of Human Fibrinogen Produced by Plasmin: III. THEIR NH2-TERMINAL AMINO ACIDS AND COMPARISON WITH THE “NH2-TERMINAL DISULFIDE KNOT | |
Kassis et al. | Mechanism of action of cholera toxin on intact cells. Generation of A1 peptide and activation of adenylate cyclase. | |
DK0710228T3 (da) | Hydraziner med N3S-konfiguration som radionuclidchelatorer | |
NO20051950L (no) | Konjugater av et polypeptid og en biokompatibel polymer | |
AU2387088A (en) | Cationized antibodies for delivery through the blood-brain barrier | |
DE69434384D1 (de) | Metalkomplexbildner | |
Reid et al. | Structural relationships between human erythrocyte sialoglycoproteins β and γ and abnormal sialoglycoproteins found in certain rare human erythrocyte variants lacking the Gerbich blood-group antigen (s) | |
DK0413188T3 (da) | Fremgangsmåde til fremstilling af umodificerede, intravenøst administrerbare IgM- og/eller IgA-holdige immunglobulinpræparater | |
ATE158082T1 (de) | Bestimmung von peptidmotiven auf mhc-molekülen | |
AU5492786A (en) | Boronic acid adducts of technetium-99m doxime complexes | |
Ronda et al. | High-and low-affinity PEGylated hemoglobin-based oxygen carriers: Differential oxidative stress in a Guinea pig transfusion model | |
NO975862L (no) | P-selektinligander og relaterte molekyler og fremgangsmåter | |
SE8301795L (sv) | Plasminogenaktivatorkomplex | |
EP0393895A3 (en) | Silicometallate molecular sieves and their use as catalysts in oxidation of alkanes | |
Sha’Afi et al. | Membrane water channels and SH-groups | |
DE3773077D1 (de) | Immunotoxine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
Kavanaugh et al. | Affinity labeling of hemoglobin with 4, 4'-diisothiocyanostilbene-2, 2'-disulfonate: covalent cross-linking in the 2, 3-diphosphoglycerate binding site | |
Guillochon et al. | Studies on haemoglobin immobilized by cross-linking with glutaraldehyde cross-lInked soluble polymers and artificial membranes | |
Parkhurst et al. | Kinetics of the reaction of hybrid-heme hemoglobins with carbon monoxide | |
MX9710114A (es) | Ligandos de p-selectina y moleculas y metodos relacionados. |